A detailed history of First Trust Advisors LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 107,882 shares of PTCT stock, worth $4.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,882
Previous 78,599 37.26%
Holding current value
$4.99 Million
Previous $2.4 Million 66.54%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.39 - $37.66 $889,910 - $1.1 Million
29,283 Added 37.26%
107,882 $4 Million
Q2 2024

Aug 13, 2024

SELL
$24.69 - $40.12 $33.5 Million - $54.4 Million
-1,356,881 Reduced 94.52%
78,599 $2.4 Million
Q1 2024

May 13, 2024

BUY
$24.15 - $31.95 $34.7 Million - $45.9 Million
1,435,480 New
1,435,480 $41.8 Million
Q3 2023

Nov 13, 2023

SELL
$22.41 - $41.99 $476,862 - $893,505
-21,279 Reduced 41.06%
30,539 $684,000
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $782,790 - $1.15 Million
19,376 Added 59.73%
51,818 $2.11 Million
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $1.64 Million - $2.1 Million
-42,921 Reduced 56.95%
32,442 $1.57 Million
Q4 2022

Feb 09, 2023

SELL
$33.53 - $54.79 $686,560 - $1.12 Million
-20,476 Reduced 21.36%
75,363 $2.88 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $1.57 Million - $2.02 Million
37,437 Added 64.1%
95,839 $4.81 Million
Q2 2022

Aug 12, 2022

BUY
$25.6 - $45.23 $576,588 - $1.02 Million
22,523 Added 62.77%
58,402 $2.34 Million
Q1 2022

May 13, 2022

BUY
$33.33 - $44.6 $745,858 - $998,058
22,378 Added 165.75%
35,879 $1.34 Million
Q4 2021

Feb 08, 2022

BUY
$35.36 - $41.86 $477,395 - $565,151
13,501 New
13,501 $538,000
Q2 2021

Aug 16, 2021

SELL
$37.95 - $49.37 $2.12 Million - $2.75 Million
-55,740 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$46.8 - $68.92 $2.61 Million - $3.84 Million
55,740 New
55,740 $2.64 Million
Q4 2020

Feb 02, 2021

SELL
$47.96 - $67.64 $2.37 Million - $3.34 Million
-49,389 Closed
0 $0
Q3 2020

Nov 05, 2020

SELL
$45.41 - $57.07 $397,019 - $498,963
-8,743 Reduced 15.04%
49,389 $2.31 Million
Q2 2020

Jul 22, 2020

BUY
$42.56 - $54.98 $511,188 - $660,364
12,011 Added 26.04%
58,132 $2.95 Million
Q1 2020

May 06, 2020

BUY
$32.37 - $59.36 $1.49 Million - $2.74 Million
46,121 New
46,121 $2.06 Million
Q4 2019

Feb 03, 2020

SELL
$32.22 - $50.07 $1.59 Million - $2.48 Million
-49,459 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$33.82 - $48.17 $589,448 - $839,554
17,429 Added 54.41%
49,459 $1.67 Million
Q2 2019

Jul 30, 2019

SELL
$35.42 - $45.0 $1.82 Million - $2.31 Million
-51,372 Reduced 61.6%
32,030 $1.44 Million
Q1 2019

May 09, 2019

SELL
$28.09 - $39.49 $540,844 - $760,340
-19,254 Reduced 18.76%
83,402 $3.14 Million
Q4 2018

Feb 07, 2019

SELL
$29.83 - $46.51 $1.79 Million - $2.79 Million
-59,904 Reduced 36.85%
102,656 $3.52 Million
Q3 2018

Oct 25, 2018

BUY
$33.9 - $47.77 $640,811 - $902,996
18,903 Added 13.16%
162,560 $7.64 Million
Q2 2018

Aug 02, 2018

BUY
$25.7 - $47.88 $3.69 Million - $6.88 Million
143,657 New
143,657 $4.85 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.